Shares of Conceptus Inc. (NASDAQ: CPTS) rallied about 19.40% by afternoon trade after Bayer AG said that it has agreed to acquire Conceptus in deal estimated at euro 852 million ( $1.1 billion ) as the health-care company looks to gain traction in women contraceptive market. Bayer said that in next 10 days period, it will issue a tender with a proposal to buy all of Conceptus’s stock, valuing each share at $31 in cash, which represents a 20% premium over Friday’s closing stock price. The deal is likely to close by the second quarter of this year.
Continue reading Major Movers on April 29; CPTS, NIHD, VRX, ACT, SINA, MDSO, GALT